ARCHIVES

Novartis Submits Gleevec Data To FDA Seeking Approval For Use In GI Tumors.

This article is from The Cancer Letter archive.

Vol. 27 No. 39 | October 26, 2001

Download PDF Visit The Full Archive

Related Articles

Final Issue of ‘76

December 10, 1976

In Brief: David Nathan receives Lifetime Impact Award from Boston Children’s Hospital

November 7, 2014

FDA Approves Manufacturer Of IVAX Paclitaxel Ingredient.

June 29, 2001

NC-Approved Clinical Trials

June 27, 2003

NCI Names Brawly Director of Office of Special Populations

June 21, 1996

NIH to ban consulting by top officials, limit outside work by other employees.

June 25, 2004